All companies
Agilent Technologies logo

What smart money is saying about Agilent TechnologiesUnited States flag

A · Healthcare · Medical - Diagnostics & Research · Market cap $38.74B

1 fund in our archive has pitched Agilent Technologies — most recently Generation IM in March 2025.

Company profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Get an email when a fund writes about it

Summarize with Warren AI
1
Reported positions
0
Bought
0
Sold
2
Letters

Position history

Between Q1 2025 and Q2 2026, 1 fund letter reported a position in Agilent Technologies, with no move described.

Fund letters reporting a position in Agilent Technologies, by quarter
QuarterLettersBoughtSoldTheses
Q2 20261000
Q1 20250001

Fund activity · 1 position

  • HoldsGuinness Global Quality Mid Cap Fund
    June 2026

    Listed in Guinness Global Quality Mid Cap Fund’s reported holdings.

    Read the letterAgilent Technologies

Fund coverage · 1 thesis

  • Generation IM
    March 2025

    Agilent is well-positioned for growth due to its strong market position in analytical instruments, resilient recurring revenue streams, and emerging demand drivers, despite short-term challenges from economic uncertainty.

    Read the full thesis

Read every full thesis on Agilent Technologies

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger